COSM
Cosmos Health Inc.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.41
P/S
0.14
EV/EBITDA
-1.92
DCF Value
$-4.94
FCF Yield
-121.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
11.4%
Operating Margin
-23.9%
Net Margin
-31.0%
ROE
-74.3%
ROA
-26.7%
ROIC
-31.1%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $17.1M | $-5.4M | $-0.17 |
| Q2 2025 | $14.7M | $-2.8M | $-0.10 |
| Q1 2025 | $13.7M | $-818.1K | $-0.03 |
| Q4 2024 | $14.2M | $-9.5M | $-0.50 |
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
4.46
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.